Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK RIKKE UDBY ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.5% 1.9% 1.6% 1.6% 3.2% 1.9% 16.7% 16.7%   Credit score (0-100)   78 72 75 73 55 68 10 10   Credit rating   A A A A BBB A BB BB   Credit limit (kDKK)   8.0 0.6 3.8 2.5 0.0 0.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,963 3,061 2,493 2,682 2,309 2,729 0.0 0.0   EBITDA   834 795 777 837 231 346 0.0 0.0   EBIT   717 674 635 503 94.0 244 0.0 0.0   Pre-tax profit (PTP)   707.3 661.3 610.6 491.7 84.7 228.1 0.0 0.0   Net earnings   551.2 515.5 461.4 382.9 61.4 173.2 0.0 0.0   Pre-tax profit without non-rec. items   707 661 611 492 84.7 228 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,048 1,014 1,372 1,064 927 825 0.0 0.0   Shareholders equity total   890 756 817 800 487 542 295 295   Interest-bearing liabilities   178 124 415 327 236 150 0.0 0.0   Balance sheet total (assets)   1,615 1,357 1,813 1,680 1,123 1,162 295 295   Net Debt   -183 5.1 169 -5.4 228 64.1 -295 -295     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,963 3,061 2,493 2,682 2,309 2,729 0.0 0.0   Gross profit growth   -1.8% 3.3% -18.6% 7.6% -13.9% 18.2% -100.0% 0.0%   Employees   5 5 5 4 5 6 0 0   Employee growth %   0.0% 0.0% 0.0% -20.0% 25.0% 20.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,615 1,357 1,813 1,680 1,123 1,162 295 295   Balance sheet change%   0.8% -16.0% 33.6% -7.4% -33.1% 3.4% -74.6% 0.0%   Added value   834.2 795.0 776.9 837.1 427.9 346.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -218 -155 216 -642 -274 -205 -825 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   24.2% 22.0% 25.5% 18.8% 4.1% 8.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   44.6% 45.4% 40.0% 28.8% 6.7% 21.4% 0.0% 0.0%   ROI %   59.5% 59.3% 50.2% 36.2% 8.7% 29.2% 0.0% 0.0%   ROE %   63.7% 62.6% 58.7% 47.3% 9.5% 33.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   55.1% 55.7% 45.1% 47.6% 43.3% 46.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -21.9% 0.6% 21.8% -0.6% 98.4% 18.5% 0.0% 0.0%   Gearing %   20.0% 16.4% 50.8% 40.8% 48.6% 27.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.0% 8.7% 8.9% 3.1% 3.3% 8.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 0.8 0.9 1.2 0.4 0.7 0.0 0.0   Current Ratio   1.1 0.9 0.9 1.3 0.5 0.8 0.0 0.0   Cash and cash equivalent   361.4 118.8 245.8 332.2 8.9 86.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   67.1 -42.8 -36.2 127.7 -142.4 -69.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   167 159 155 209 86 58 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   167 159 155 209 46 58 0 0   EBIT / employee   143 135 127 126 19 41 0 0   Net earnings / employee   110 103 92 96 12 29 0 0